412 related articles for article (PubMed ID: 31318766)
1. Locally Excised T1 Rectal Cancers: Need for Specialized Surveillance Protocols.
Kwakye G; Curran T; Uegami S; Finne CO; Lowry AC; Madoff RD; Jensen CC
Dis Colon Rectum; 2019 Sep; 62(9):1055-1062. PubMed ID: 31318766
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic Versus Open Surgery for Locally Advanced Rectal Cancer: Five-Year Survival Outcomes in a Large, Multicenter, Propensity Score-Matched Cohort Study.
Nishizaki D; Hida K; Sumii A; Okamura R; Sakai Y; Konishi T; Akiyoshi T; Maruyama S; Okajima M; Miyakura Y; Yamamoto S; Morita S; Watanabe M;
Dis Colon Rectum; 2022 Aug; 65(8):1005-1014. PubMed ID: 34775411
[TBL] [Abstract][Full Text] [Related]
4. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
[TBL] [Abstract][Full Text] [Related]
5. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
[TBL] [Abstract][Full Text] [Related]
6. Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer.
Maykel JA; Hahn SJ; Beauharnais CC; Meyer DC; Hill SS; Sturrock PR; Davids JS; Alavi K
Dis Colon Rectum; 2022 Jun; 65(6):827-836. PubMed ID: 34629431
[TBL] [Abstract][Full Text] [Related]
7. Oncological Outcomes of Transanal Endoscopic Surgery for the Surgical Management of T2 and T3 Rectal Cancer.
Johnson GGRJ; Robertson RL; Vergis A; Raval M; Phang T; Karimuddin A; Brown C
Dis Colon Rectum; 2023 Jul; 66(7):1012-1021. PubMed ID: 36876985
[TBL] [Abstract][Full Text] [Related]
8. Completion Surgery in Unfavorable Rectal Cancer after Transanal Endoscopic Microsurgery: Does It Achieve Satisfactory Sphincter Preservation, Quality of Total Mesorectal Excision Specimen, and Long-term Oncological Outcomes?
Serra-Aracil X; Galvez Saldaña A; Mora-Lopez LL; Montes N; Pallisera-Lloveras A; Serra-Pla S; Pericay C; Navarro-Soto S
Dis Colon Rectum; 2021 Feb; 64(2):200-208. PubMed ID: 33315715
[TBL] [Abstract][Full Text] [Related]
9. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
[TBL] [Abstract][Full Text] [Related]
10. Local Recurrence-Free Survival After TaTME: A Canadian Institutional Experience.
Hershorn O; Ghuman A; Karimuddin AA; Raval MJ; Phang PT; Brown CJ
Dis Colon Rectum; 2024 May; 67(5):664-673. PubMed ID: 38319633
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Preoperative and Postoperative Serum CEA and Carbohydrate Antigen 19-9 Levels in Patients Undergoing Curative Resection of Locally Recurrent Rectal Cancer.
Paku M; Uemura M; Kitakaze M; Miyoshi N; Takahashi H; Mizushima T; Doki Y; Eguchi H
Dis Colon Rectum; 2023 Mar; 66(3):392-400. PubMed ID: 36649161
[TBL] [Abstract][Full Text] [Related]
12. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
[TBL] [Abstract][Full Text] [Related]
13. Radiologic Factors and Areas of Local Recurrence in Locally Advanced Lower Rectal Cancer After Lateral Pelvic Lymph Node Dissection.
Shiraishi T; Sasaki T; Tsukada Y; Ikeda K; Nishizawa Y; Ito M
Dis Colon Rectum; 2021 Dec; 64(12):1479-1487. PubMed ID: 34657076
[TBL] [Abstract][Full Text] [Related]
14. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
Park SY; Lee SM; Park JS; Kim HJ; Choi GS
Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
[TBL] [Abstract][Full Text] [Related]
15. Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?
Garoufalia Z; Freund MR; Gefen R; Meyer R; DaSilva G; Weiss EG; Wexner SD
Dis Colon Rectum; 2023 Jul; 66(7):898-904. PubMed ID: 36649177
[TBL] [Abstract][Full Text] [Related]
16. Size Criteria Is Not Sufficient in Selecting Patients for Local Excision Versus Radical Excision for Rectal Neuroendocrine Tumors >2 cm: A National Cancer Database Analysis.
Izquierdo KM; Humphries MD; Farkas LM
Dis Colon Rectum; 2021 Apr; 64(4):399-408. PubMed ID: 33651006
[TBL] [Abstract][Full Text] [Related]
17. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
[TBL] [Abstract][Full Text] [Related]
18. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
[TBL] [Abstract][Full Text] [Related]
19. Uptake of Total Mesorectal Excision and Total Mesorectal Excision Grading for Rectal Cancer: A Statewide Study.
Kanters AE; Cleary RK; Obi SH; Asgeirsson T; Evilsizer SK; Fasbinder LG; Campbell DA; Hendren SK
Dis Colon Rectum; 2020 Jan; 63(1):53-59. PubMed ID: 31633602
[TBL] [Abstract][Full Text] [Related]
20. Correlation Between the Distance to Mesorectal Fascia and Prognosis of cT3 Rectal Cancer: Results of a Multicenter Study From China.
Zhang XY; Li XT; Shi YJ; Lu QY; Cao W; Zhang HM; Wang L; Zhu HT; Yu T; Guan Z; Sun RJ; Zhu HB; Wu AW; Sun YS
Dis Colon Rectum; 2022 Mar; 65(3):322-332. PubMed ID: 34459446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
